Cases 111 - 120 of 241
Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01674
Plaintiff:
Allergan USA, Inc., Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company and others
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ACTELION PHARMACEUTICALS LTD v. AUROBINDO PHARMA USA INC. et al
as 3:2019cv15437
Defendant:
AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LIMITED
Plaintiff:
ACTELION PHARMACEUTICALS LTD
Cause Of Action: 15 U.S.C. § 1126
SENJU PHARMACEUTICAL CO., LTD et al v. AUROBINDO PHARMA USA INC. et al
as 3:2019cv13348
Defendant:
AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LIMITED
Plaintiff:
SENJU PHARMACEUTICAL CO., LTD, BAUSCH & LOMB INCORPORATED and BAUSCH & LOMB PHARMA HOLDINGS CORP.
Cause Of Action: 35 U.S.C. § 271
ASTRAZENECA PHARMACEUTICALS LP et al v. AUROBINDO PHARMA LIMITED et al
as 3:2019cv12567
Defendant:
AUROBINDO PHARMA USA INC. and AUROBINDO PHARMA LIMITED
Plaintiff:
ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED and ASTRAZENECA AB
Cause Of Action: 35 U.S.C. § 271
Arena Pharmaceuticals, Inc. et al v. Aurobindo Pharma Limited et al
as 1:2019cv00811
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Plaintiff:
Eisai Inc., 356 Royalty Inc. and Arena Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al. v. Aurobindo Pharma, Ltd. et al.
as 1:2019cv00748
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialties Ltd.
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. AUROBINDO PHARMA LIMITED et al
as 3:2019cv08840
Plaintiff:
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LIMITED
Cause Of Action: 15 U.S.C. § 1126
Millennium Pharmaceuticals, Inc. v. Aurobindo Pharma USA Inc. et al
as 1:2019cv00471
Plaintiff:
Millennium Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
